Entero Healthcare Solutions growth over the years

·Consumer ServicesChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Compounded a year1 yr3 yr
Revenue+29.4%—
EBITDA+55.1%—
Net Income+35.8%—
EPS (adj.)+21.3%—
Total Assets+33.2%+40.1%
Total Equity−1.0%+43.1%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ENTERO₹1,559.30

Entero Healthcare Solutions Ltd.

· Consumer Services
₹ CrorePeersMEDPLUSEMILCRIZACGPPLCMSINFOHEMIPROPBLACKBUCKINOXGREENMcap ₹6,785 Cr
Annuals · FY-end closes
Compounded Growth
Annuals · CAGR %
1Y
CAGR
3Y
CAGR
Revenue+29.4—
EBITDA+55.1—
Net Income+35.8—
EPS (adj.)+21.3—
Total Assets+33.2+40.1
Total Equity-1.0+43.1
CAGR from filed annuals — needs positive start & end values.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.